Testing the safety of ATB-320 for advanced solid tumors
Part of Cancer clinical trials.
This early-phase trial tests a new drug called ATB-320 for people with solid tumors that have spread or are growing despite standard treatment. It aims to see if the drug is safe and tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a solid tumor (not a blood cancer) that has spread or is getting worse.
- You must have tried standard treatments and they didn't work or you couldn't tolerate them.
- You need to have a tumor sample available from a past biopsy or be able to have a new biopsy safely.
- You should be able to take care of yourself and do light activities (ECOG score 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, BNT3214, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if BNT3214 is safe and helps shrink tumors.
This trial tests a new drug, BTM-3566, for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug called T320, which is designed to target and kill cancer cells. It is for people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists.
This trial tests an experimental tablet called TQB3217 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and helps shrink or control the tumor.
This trial tests a new drug called BNT3212, either alone or combined with BNT327, in people with advanced solid tumors that have not gotten better with standard treatments. The goal is to find safe doses and see if the drugs can shrink tumors or slow their growth.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.